Previous 10 | Next 10 |
Acceleron Pharma (NASDAQ: XLRN ) initiated with Outperform rating and $78 (84% upside) price target at Cowen and Company. More news on: Acceleron Pharma Inc., EXACT Sciences Corporation, Kadmon Holdings, Healthcare stocks news, Stocks on the move, , Read more ...
Orthofix Medical Inc. (OFIX) Q4 2018 Results Conference Call February 25, 2019 04:30 PM ET Company Participants Mark Quick - Senior Director, Business Development and IR Brad Mason - President and CEO Doug Rice - CFO Brad Niemann - President, Spine Conference Call Participan...
Orthofix (NASDAQ: OFIX ): Q4 Non-GAAP EPS of $0.55 beats by $0.07 ; GAAP EPS of $0.47 beats by $0.09 . More news on: Orthofix International N.V., Earnings news and commentary, Healthcare stocks news, Read more ...
Fourth Quarter Highlights Net sales of $121.1 million, an increase of 3.6% compared to prior year and 4.4% on a constant currency basis Net income of $8.9 million; compared to net income from continuing operations of $1.5 million in the prior year Adjusted EBITDA of $24.4 mill...
ALSN , APLE , APTS , ATH , AWR , BWXT , CDEV , CORT , CRZO , DRH , ELGX , EPR , ETSY , FRAC , FRGI , GSM , HNI , HTZ , IMMU , JBT , KAMN , KBR , LSI , MEDP , MOS , NGHC , NLS , OFIX , OKE , PBPB , PEB , PLOW , PODD , QTS , RCII , RP , RRC , SHAK , SNHY...
The FDA approves Orthofix Medical's (NASDAQ: OFIX ) M6-C artificial cervical disc for patients with cervical disc degeneration. More news on: Orthofix International N.V., Healthcare stocks news, Read more ...
Only Artificial Cervical Disc that Mimics the Anatomic Structure of a Natural Disc Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced U.S. Food and Drug Administration (FDA) approval of the M6-C ...
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans to release financial results for the fourth quarter and fiscal 2018 after market close on Monday, February 25, 2019. Brad Mason, Chief Executi...
Former medical device distributor partner will now be a part of the Orthofix direct sales team Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it has acquired the business of Options Medical, ...
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that President and Chief Executive Officer Brad Mason will present at the J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 10, 2019 a...
News, Short Squeeze, Breakout and More Instantly...
Orthofix Medical Inc. Company Name:
OFIX Stock Symbol:
NASDAQ Market:
Orthofix Medical Inc. Website:
Wednesday, August 14, 2024 at 2:30 pm Eastern Time Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the Company will participate in Canaccord Genuity's 44th Annual Growth Conference in Boston. Management is scheduled to pre...
Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Stephanie Walsh as Chief Human Resources Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240716004...
Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510(k) clearance and first U.S. implant of the Fitbone ™ Transport and Lengthening System. Used to treat large bone defects in the femur and tibia due to trauma, infectious or ma...